---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-005805"
form_type: "8-K"
ticker: "CELZ"
cik: "0001187953"
company_name: "CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC."
filed_at: "2026-09-25T21:00:47+00:00"
generated_at: "2026-10-12T13:26:30.726440+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CELZ buys 4M BioDefense shares for $200K cash plus 1M CELZ shares, lifting stake to 80%

## Summary
- Creative Medical Technology Holdings acquired 4,000,000 BioDefense, Inc. shares from Creative Acquisition Corp. for $200,000 cash plus 1,000,000 CELZ common shares; closing Sept. 24, 2026.
- After the deal CELZ holds 16,000,000 BioDefense shares (80% of outstanding), with seller CAC retaining 4,000,000 shares (20%).
- CAC is controlled by CELZ President/CEO Timothy Warbington, who is Chairman/CEO of CAC and indirectly owns all of its stock, making this a related-party transaction.
- The 1,000,000 CELZ shares were issued in a private placement under Section 4(a)(2) of the Securities Act and are unregistered, with transfer restrictions noted in the agreement.
- Agreement executed by Warbington for CAC and CFO Donald Dickerson for CELZ; governed by Nevada law, with a Stock Power transferring the 4M BioDefense shares.

## SEC filing metadata
- accession: 0001477932-26-005805
- form_type: 8-K
- ticker: CELZ
- cik: 0001187953
- company_name: CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
- filed_at: 2026-09-25T21:00:47+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1187953/000147793226005805/0001477932-26-005805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1187953/000147793226005805/celz_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-005805
- JSON: https://secwatch.observer/filing/0001477932-26-005805.json
- Plain text: https://secwatch.observer/filing/0001477932-26-005805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.